Menu
Back to Journals » International Journal of Nanomedicine » Volume 11
Original Research
A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 7,820 | Dovepress* | 3,930 | 2,978+ | 1,077 | 6,908 |
| PubMed Central* | 0 | 912 | 277 | 912 | |
| Totals | 3,930 | 3,890 | 1,354 | 7,820 | |
|
*Since 8 January 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 4 | 4 |
View citations on PubMed Central and Google Scholar